Diagnosis and management of heart failure: Implications of the recent European Society of Cardiology Guidelines for the older patient

Age and Ageing

Volumn 32, Issue 6, 2003, Pages 563-565

  Gillespie, Neil D ^a   McMurdo, Marion E T ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; VALSARTAN;

AGED; ARTICLE; CARDIOLOGY; DIAGNOSTIC VALUE; DIET RESTRICTION; DRUG TOLERABILITY; DYSPNEA; ECHOCARDIOGRAPHY; EUROPEAN UNION; GERIATRIC CARE; GERIATRIC PATIENT; HEART FAILURE; HUMAN; KINESIOTHERAPY; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SCREENING TEST; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIGOXIN; DIURETICS; DRUG INTERACTIONS; ECHOCARDIOGRAPHY; EUROPE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; NATRIURETIC PEPTIDE, BRAIN; PRACTICE GUIDELINES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0344897725     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afg106     Document Type: Article

References (31)

1. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
2. McDonagh TA, Morrison CE, Lawrence A. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-33.
3. Mosterd A, Hoes AW, Bruijne de MC et al. Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam Study. Eur Heart J 1999; 20: 447-55.
4. Morgan S, Smith H, Simpson I. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional study. Br Med J 1999; 318: 368-72.
5. Aronow WS, Ahn C, Kronzon I. Prevalence of echocardiographic findings in 554 men and 1243 women aged >60 years in a long term care health facility. Am J Cardiol 1997; 79: 379-80.
6. Luchi RJ, Taffet GE, Teasdale TA. Congestive heart failure in the elderly. J Am Geriatr Soc 1991; 39: 810-25.
7. Remes J, Miettinen H, Reunamen A, Phyoral K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
8. Ho SF, O'Mahony S, Steward JA, Breay P, Buchalter M, Burr M. Dyspnoea and quality of life in older people at home. Age Ageing 2001; 30: 155-9.
9. Smith E. A survey of peripheral oedema in elderly patients admitted to a geriatric ward. Br J Clin Pract 1996; 50: 20-1.
10. Cowie MR, Fox K, Wood DA et al. Hospitalisation of patients with heart failure. Eur Heart J 2002; 23: 877-85.
11. Cowie MR, Zaphiriou A. Management of chronic heart failure. Br Med J 2002; 325: 422-5.
12. McDonagh TA, Cunningham AD, Morrison CD. Left ventricular dysfunction, natriuretic peptides and mortality in an urban population. Heart 2001; 86: 21-6.
13. Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997; 77: 264-7.
14. Hall C, Rouleau JL, Moye L et al. N-terminal proatrial natriuretic factor. An independent predictor of long term prognosis after myocardial infarction. Circulation 1994; 89: 1934-42.
15. Hutcheon SD, Gillespie ND, Struthers AD, McMurdo MET. B-type natriuretic peptide in the diagnosis of cardiac disease in elderly day hospital patients. Age Ageing 2002; 31: 295-301.
16. Lien CTC, Gillespie ND, Struthers AD, McMurdo MET. Heart failure in frail elderly patients: diagnostic difficulties, polypharmacy and treatment dilemmas. Eur J Heart Fail 2002; 4: 91-8.
17. Cline CMJ, Bjorck-Linne AK, Israelsson BYA, Willenheimer RB, Erhardt LR. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999; 145-9.
18. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
19. MacDowall P, Kalra PA, O'Douoghne DJ et al. Risk of co-morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13-16.
20. The RALES investigators. Effectiveness of spironolactone added to an ACE inhibitor and a loop diuretic for severe chronic congestive cardiac failure. Am J Cardiol 1996; 78: 902-7.
21. Erdman E, Lechat P, Verkenne P, Wiemann H. Results from post-hoc analyses of die CIBIS II trial: effect of bisoprolol in high risk patient groups with chronic heart failure. Eur J Heart Failure 2001; 463-79.
22. Cleland JGF, McGowan J, Clark A, Freemantle N. The evidence for beta blockers in heart failure. Br Med J 1999; 318: 824-5.
23. Rich MW, Beckham V, Wittenberg C, Leven C, Freeland KE, Carney RM. A multi-disciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N. Engl J Med 1995; 333: 1190-5.
24. Pitt B, Martinez FA, Meures G on behalf of the ELITE investigators. Randomised trial of losartan versus captopril in patients over 65 with heart failure. Lancet 1997; 349: 747-52.
25. Hulsmann M, Berger R, Sturm B et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study. ELITE II. Lancet 2000; 355: 1582-7.
26. Cohn JN, Tognoni G for the Valsartan Heart Failure Trial Investigators. A randomised trial of the angiotensin-receptor blocker valsartin in chronic heart failure. N Engl J Med 2001; 345: 1667-75.
27. Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G. Candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme investigators. J Card Fail 1999; 5: 276-82.
28. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
29. Cahalin L, Mathier M, Semigran M, Dee W, Di Salvo T. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996; 110: 325-32.
30. Demopuolos L, Bijou R, Fergus I et al. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while minimising the increase in ventricular wall stress. Circulation 1997; 29: 597-603.
31. Clark KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994; 71: 584-7.